Hyosung, with its abundant experience and expertise in facility construction for plant EPC projects, is striving to deliver ultimate customer satisfaction by providing a comprehensive solution for its customers from facility construction to standard compliance.
Based on its abundant experiences in facility building for plant EPC projects, Hyosung helps its customers in the bio and pharmaceutical industries comply with the industry standards, and provides the best solutions for its customers. In particular, Hyosung provides industry-leading planning services for manufacturing processes of non-sterilized pharmaceutical products in solid, liquid, and semi-solid forms as well as sterilized pharmaceutical products according to CGMP standards. Hyosung has gained a reputation as providing the best services from planning to optimization, engineering, validation, and construction.
Hyosung possesses industry-leading expertise in building bio-tech facilities which produce biological agents, genetically engineered pharmaceutical products, cell cultivation, cell treatment, and genetic treatment in the fields of design, engineering, validation, and construction. In particular, Hyosung has gained international recognition for its technology which comply with GMP standards while considering the optimal environment for laboratories (input, inspection, cultivation, experiment/test, operation, data recording/management, and validation).
Hyosung capabilities lie in design, construction, supply, turnkey construction and flexible services according to the needs of the customers.